- Choroideremia
- Hereditary choroidal dystrophy
- Inherited retinal degeneration
- Pigmentary retinopathy
- Retina degeneration
- Retinal angiomatosis in von Hippel-Lindau disease
- Retinitis pigmentosa
- Stargardt's disease vision
- Usher's syndrome-related retinal disorders
Tomas S. Aleman, MD
Ophthalmology
Accepting new patients
Sees patients age 4 and up
Scheie Eye Institute Perelman
Penn Medicine Provider
About me
- Director, Retinal Function and Structure Laboratories, Scheie Eye Institute
- Director, Retinal Degenerations, Scheie Eye Institute
- Director, Retinal Degeneration and Ophthalmic Genetics Fellowship Program, Scheie Eye Institute
- Irene Heinz-Given and John LaPorte Research Professor
My education and training
- INTEGRIS Rural Healthcare of OklahomaResidency
- Brookdale Hospital Medical CenterResidency
- Scheie Eye InstituteResidency
- Scheie Eye InstituteFellowship
Spoken languages
English
English
Español
Spanish
Reviews
Insurance accepted
Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.
- Aetna Advantra Cares D-SNP
- Aetna Advantra Credit Value
- Aetna Advantra Eagle HMO
- Aetna Advantra Eagle POS
- Aetna Advantra Premier Plus PPO
- Aetna Advantra Value
- Aetna Advantra Value Plus
- Aetna APCN Plus (Multi-Tier)
- Aetna Better Health Kids (CHIP) - DH Only
- Aetna Flexible Five
- Aetna Freedom Core
- Aetna Gold
- Aetna HMO
- Aetna Philly Prime
- Aetna POS
- Aetna PPO APCN
- Aetna Premier
- Aetna Premier Plus
- Aetna Savings Plus
- Aetna Signature Administrators
- Aetna Student Health Plan PPO
- Aetna Upfront Advantage
- First Health HMO
- First Health POS
- First Health PPO
- Meritain - Aramark (Other)
- Meritain - Aramark (Pennsylvania Premier Medical Plan)
- Centivo EPO
- Cigna Healthcare EPO
- Cigna Healthcare HMO
- Cigna Healthcare POS
- Cigna Healthcare PPO
- Claim Watcher (Homestead/ INDECs) Open Access
- Clover Health Choice
- Clover Health Choice Value PPO
- Clover Health Classic HMO
- Clover Health Value
- Devoted Health Choice Giveback Pennsylvania (PPO)
- Devoted Health Choice Pennsylvania (PPO)
- Devoted Health Choice Plus Pennsylvania (PPO)
- Devoted Health Core Pennsylvania (HMO)
- Devoted Health Dual Plus Pennsylvania (HMO D-SNP)
- Devoted Health Giveback Pennsylvania (HMO)
Locations
Penn Medicine hospital privileges
- Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
- Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Aleman is a Penn Medicine physician.
Qualifications and experience
- Ophthalmology, 2019
- American Academy of Ophthalmology, National
- Association for Research in Vision and Ophthalmology, International
- Cuban Society of Ophthalmology, National
- Cuban Society of Retinitis Pigmentosa, National
- The International Society for Genetic Eye Disease and Retinoblastoma, International
- The Macula Society, International
- Retina and vitreous care
Treatments and conditions
Research
Publications
Dufour VL, Sato Y, Sumaroka A, Sudharsan R, Banin E, Yu Y, Ripolles-Garcia A, Kwok J, Aleman TS, Ying GS, Sharon D, Cideciyan AV, Beltran WA, Aguirre GD PRCD-associated retinitis pigmentosa in dogs and humans , Exp Eye Res, 269: 2026,111045
Hüther A, Simon CL, Sumaroka A, O’Neil EC, Roman AJ, Kim RJ, Weber , Garafalo AV, Cideciyan AV, Aleman TS Bi-allelic pathogenic variants in NR2E3 may be associated with a subtle enhanced S-cone syndrome phenotype , Ophthalmic Genetics, 30: 2026,1-7
Aleman TS, Cideciyan AV Measuring vision in children undergoing retinal gene therapy , JAMA Ophthalmol, 144(2): 2026,165-166
Cideciyan AV, Aleman TS Gene therapy for young children with congenital blindness , The Lancet, 144(2): 2026,165-166
Zhang S, Avery RA, Wu V, Sumaroka A, Kim RJ, Maripuri DP, Datz E, Weber ML, Roman SJ, Tsang SH, Cideciyan AV, Aleman TS, O’Neil EC A Spectrum of severity of a unifying retinal phenotype in TUBB4B-associated inherited retinal degeneration , Retina Cases and Brief Reports: 2026
Aleman TS, Cideciyan AV. Measuring vision in children undergoing retinal gene therapy , JAMA Ophthalmol, 144(2): 2026,165-166
Cideciyan AV, Aleman TS. Gene therapy for young children with congenital blindness , The Lancet, 144(2): 2026,165-166
Hüther A, Simon CL, Sumaroka A, O’Neil EC, Roman AJ, Kim RJ, Weber , Garafalo AV, Cideciyan AV, Aleman TS. Bi-allelic pathogenic variants in NR2E3 may be associated with a subtle enhanced S-cone syndrome phenotype , Ophthalmic Genetics, 30: 2026,1-7
Aleman TS, Weber ML, Roman AJ, Swider M, Uyhazi KE, Kim RJ, Maguire K, Aleman EM, Parchinski K, O’Neil EC, Sumaroka A, Santos A, Sun J, Wu V, Garafalo AV, Viarbitskaya I, Magrath G, Jayagopal A, Yerxa B, Tucker S, Tuller S, Maguire AM, Scoles D, Bennett J, Cideciyan AV. Restoration of cone-mediated vision after gene augmentation in children with LCA5 , Invest. Ophthalmol. Vis. Sci.: 2026
Everett L, Nagiel A, Lam BL, Aleman TS, Lauer AK, Berrocal AM, Gregori NZ, Boye SE, Boye SL, Pardon LP, Yoon D, Kay CN, Fujita K. Safety and efficacy of ATSN-201 in patients with X-linked retinoschisis: 12-month dose finding results of the LIGHTHOUSE study , Invest. Ophthalmol. Vis. Sci.: 2026